Inflammatory factor-mediated miR-155/SOCS1 signaling axis leads to Treg impairment in systemic lupus erythematosus
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.113013 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Juan Yu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, The First People's Hospital of Yunnan Province, The Affliated Hospital of Kunming University of Science and Technology, K…. Hauptthemen laut MEDLINE: MicroRNAs, Suppressor of Cytokine Signaling 1 Protein, Lupus Erythematosus, Systemic, T-Lymphocytes, Regulatory. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Systemic lupus erythematosus (SLE) is an autoimmune disorder associated with the decrease and functional impairment of regulatory T cells (Tregs). In the current study, we explored the interplay of miR-155 and suppressor of cytokine signaling 1 (SOCS1) in regulating Treg function and stability in SLE. METHODS: Clinical samples from healthy subjects and SLE patients were collected, and a mouse model of SLE was established to profile the expression pattern of miR-155 and SCOS1 in Tregs. Tregs isolated from mouse spleen were stimulated by inflammatory cytokines to confirm involvement of miR-155/SOCS1 axis in dictating Treg stability and function. We also administrated synthetic miR-155 inhibitor in SLE animal model to evaluate the potential effect on rescuing Treg function and alleviating SLE progression. RESULTS: Tregs from SLE patients and SLE-induced mice exhibited a downregulation of SOCS1 and an upregulation of miR-155. In Tregs stimulated by inflammatory cytokines, Nuclear factor kappa B (NF-κB) signaling activation was required for the change of SOCS1 and miR-155 expression. miR-155 served as a negative regulator to dampen SOCS1 expression in inflammation-stimulated Tregs. The transfection of miR-155 mimic impaired the suppressive function and differentiation of Tregs through targeting SOCS1. In contrast, miR-155 inhibition improved Treg function under inflammatory stimulation and alleviated SLE conditions in the mouse model. CONCLUSION: Inflammation-induced miR-155 impairs Treg stability and function in SLE through decreasing SOCS1 expression. Targeting miR-155 might be developed as an intervention to mitigate SLE conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, The First People's Hospital of Yunnan Province, The Affliated Hospital of Kunming University of Science and Technology, Kunming 650032, Yunnan, China.
- Department of Rheumatology, The First People's Hospital of Yunnan Province, The Affliated Hospital of Kunming University of Science and Technology, Kunming 650032, Yunnan, China. Electronic address: zijing_yin@126.com.
Zitieren
APA
Yu, J., Mei, J., Zuo, D., Zhang, M., Yu, S., Li, F., Wang, J., Bi, D., Ma, S., Wang, J., & Yin, Z. J. (2024). Inflammatory factor-mediated miR-155/SOCS1 signaling axis leads to Treg impairment in systemic lupus erythematosus. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113013
Vancouver
Yu J, Mei J, Zuo D, Zhang M, Yu S, Li F, et al. Inflammatory factor-mediated miR-155/SOCS1 signaling axis leads to Treg impairment in systemic lupus erythematosus. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113013
BibTeX
@article{Yu2024,
author = {Yu, Juan and Mei, Jian and Zuo, Dachen and Zhang, Mingxing and Yu, Shengnan and Li, Fayou and Wang, Juan and Bi, Danyan and Ma, Sha and Wang, Jing and Yin, Zi-Jing},
title = {Inflammatory factor-mediated miR-155/SOCS1 signaling axis leads to Treg impairment in systemic lupus erythematosus},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.113013}
}
EUVIMED